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Inflammasomes are large multiprotein complexes localized in the cytoplasm of the cell. They are responsible for
the maturation of pro-inflammatory cytokines such as interleukin-1b (IL-1b) and IL-18 as well as for the
activation of inflammatory cell death, the so-called pyroptosis. Inflammasomes assemble in response to cellular
infection, cellular stress, or tissue damage; promote inflammatory responses and are of great importance in
regulating the innate immune system in chronic inflammatory diseases such as periodontitis and several chronic
systemic diseases. In addition to sensing cellular integrity, inflammasomes are involved in the homeostatic
mutualism between the indigenous microbiota and the host. There are several types of inflammasomes of which
NLRP3 is best characterized in microbial pathogenesis. Many opportunistic bacteria try to evade the innate
immune system in order to survive in the host cells. One of these is the periodontopathogen Porphyromonas
gingivalis which has been shown to have several mechanisms of modulating innate immunity by limiting the
activation of the NLRP3 inflammasome. Among them, ATP-/P2X7- signaling is recently associated not only
with periodontitis but also with development of several systemic diseases. The present paper reviews multiple
mechanisms through which P. gingivalis can modify innate immunity by affecting inflammasome activity.
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T
he innate immune system is the first line of de-
fense against microbial pathogens. It is initiated
by genome-encoded pattern recognition receptors
(PRRs) that respond to invading microorganisms. PRRs
recognize microbial pathogen-associated molecular pat-
terns (PAMPs). This leads to activation of host defense
pathways to clear the infection (1). In addition to micro-
bial components, the receptors can respond to danger-
associated molecular patterns (DAMPs) derived from
the host (ATP, DNA, cholesterol crystals). Also envi-
ronmental irritants such as asbestos, silica, alum, and
nanoparticles can stimulate inflammasome-driven inflam-
mation (2, 3). In the detection of pathogens, toll-like
receptors (TLRs) are of crucial importance. They recog-
nize distinct PAMPs and participate in the first line of
defense against invading pathogens, playing a signifi-
cant role in inflammation and immune cell regulation.
Other well characterized evolutionary conserved PRRs
involved in innate immune defense are retinoic acid-
inducible gene-I (RIG-I) receptors, C-type lectin recep-
tors (CLRs), and nucleotide-binding domain (NOD)-like
receptors (4, 5). All these receptors are expressed by
several cell types such as macrophages, neutrophils,
monocytes, and epithelial cells (6).
The activation of PRRs and their post-receptor sig-
naling can stimulate recruitment of the so-called in-
flammasome complexes (1, 3, 615). Inflammasome is
a relatively new concept introduced by Tschopp et al. in
2002 (7). Later, Tschopp also introduced the concept
of metabolic syndrome that senses metabolic stress and
contributes to the metabolic syndrome associated with
obesity and type 2 diabetes (16).
The aims of the present paper are to give a brief
description of inflammasome compositions and functions
and to systematically review how Porphyromonas gingivalis,
a putative keystone pathogen in chronic periodontitis (17),
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well known for its way to manipulate the innate immune
system (18), may carry out/modulate inflammasome
activation in chronic periodontitis and certain other
chronic systemic infections. The role of inflammasome
and danger molecule signaling in the oral cavity was
recently reviewed by Yilmaz and Lee (6).
Inflammasomes
Inflammasomes are multiprotein complexes localized
within the cytoplasm of the cell. They are engaged in
the maturation of pro-inflammatory cytokines such as
interleukin-1b (IL1-b) and interleukin-18 (IL-18) (19).
After infection or cellular stress, inflammasomes are
assembled, activated, and involved in host defense and
in the pathophysiology of diseases (20). Inflammasomes
follow canonical or non-canonical pathways. A typical
functional canonical inflammasome complex consists of
a nucleotide-binding leucine-rich repeat (NLR) protein,
an adaptor molecule apoptosis-associated speck-like
protein containing a caspase activation and recruitment
domain (ASC) and procaspase-1 (21). A typical non-
canonical inflammasome is the one activating caspase-11,
which so far is an understudied pro-inflammatory
caspase (22).
A unique scaffolding protein (NLR) dictates the for-
mation of inflammasomes. Mutations in members of the
NLR family have been linked to various inflammatory
diseases consistent with the fact that these molecules play
an important role in hostpathogen interactions and the
inflammatory response (23). Each inflammasome con-
tains a unique sensor protein of the NLR superfamily or
the PYRIN and HIN-200 domain-containing (PYHIN)
superfamily (10). In NLRs, signaling is exerted by cas-
pase activation and the so-called caspase activation and
recruitment domains (CARDs). These can recruit caspase-1
directly or by PYRIN domains recruiting caspase-1 via
the CARD-PYRIN-containing adaptor protein ASC (10).
The adaptor protein mediates a critical step in innate
immune signaling by bridging the interaction between
the pathogen recognition receptors and caspase-1 in
inflammasome complexes (24).
Inflammasomes have a critical role in initiating innate
immune responses, particularly by acting as platforms for
activation of the inflammatory caspase proteases. Among
these, caspase-1 initiates innate immune responses by
specifically cleaving of pro-IL-1b and pro-IL-18 and
mediates their maturations and release (10). These cyto-
kines promote recruitment of phagocytes, angiogenesis,
epithelial cell repair, and regulation of cytokines and
chemokine production by other immune cells at the site
of infection or injury (reviewed by Hao et al. (25)).
Inflammasomes also take part in the host defense
independent of their classic cytokine targets IL-1b and
IL-18.
Caspase-1 and 11 can start a rapid and inflammatory
form of cell death, the so-called pyroptosis. They are
distinct from caspases classically involved in apoptosis.
Pyroptosis, a program of cellular self-destruction that is
intrinsically inflammatory, results from osmotic pressure
created by caspase-1-dependent formation of membrane
pores (26, 27) and is associated with rapid release
of cytosolic contents. This process can restrict intracel-
lular replication of invasive bacterial pathogens (28) and
probably acts in synergy with the recruitment of neu-
trophils by IL-1b to restrict replication of bacteria
in vivo (10).
Inflammasomes sense cellular integrity and tissue
health. When cell homeostasis is disrupted, inflammation
is caused by the release of cytokines. A large amount of
infectious and noxious insults can assemble these special
structures. Thus inflammasomes may have a role in
bacterial, parasitic, fungal, and viral infections (29).
Inflammasomes also sense products and endogenous
signals that indicate loss of cellular homeostasis (10, 15)
and can be active both in periodontitis and several
systemic diseases (6, 30).
Several distinct inflammasomes have currently been
described, each of which is activated by unique stimuli
(Fig. 1). Inflammasomes such as NLRP1 (nucleotide-
binding domain-like receptor protein) inflammasome1,
NLRP3, NLRP4, NLRP6, NLRP/NLRP12, and AIM2
(Absent In Melanoma 2) have been recognized acting in
the host defense against intracellularly invading patho-
gens. Some inflammasomes are particularly well char-
acterized for their role in bacterial recognition such as
NLRC4, NLRP3, and AIM2 (Fig. 1). Also there may be
more paths to IL-1b and IL-18 generation than via
caspase-1 (1). It is likely that other caspase-1-dependent
effector cytokines are produced by other proteases during
infection (31). Several pathogens have been found to
develop strategies to counteract inflammasomes (the
so-called pathogenic stealth mechanisms) (32). Thus,
Staphylococcus aureus can modify its cell wall peptido-
glycan to prevent degradation by lysozymes through
peptidoglycan O-acetyl transferase A which also strongly
suppresses inflammasome activation and inflammation
in vitro and in vivo (33).
While inflammasome activation is important to host
defense, excessive inflammasome activation can be detri-
mental to health. Inflammasome hyperactivation is re-
cently proposed to be the basis for autoinflammatory
disease pathogenesis, whereas inflammasome regulated
activity is central for appropriate host defense and protec-
tion from sepsis (16). Accordingly, there is need for a
balance between resolution of infection and excessive
inflammation (1). It should also be kept in mind that
several pathogenic bacteria, for example, Yersinia pestis,
Salmonella, and Listeria monocytogenes activate mul-
tiple inflammasomes demonstrating redundancy of
Ingar Olsen and O¨zlem Yilmaz
2
(page number not for citation purpose)
Citation: Journal of Oral Microbiology 2016, 8: 30385 - http://dx.doi.org/10.3402/jom.v8.30385
inflammatory receptors in vitro and in vivo (34, 35). It is
also possible that several NLRs, AIM2s, and caspases
co-operate during infections (1), which may be necessary
for optimal responses to be obtained.
In inflammasome-mediated cytokine release, a multi-
step activation pathway is followed. First, there is an NF-
kB-dependent upregulation of the inactive pro-forms
of IL-1b and IL-18 and of some NLRs like NLRP3;
thereafter, activation of the NLR or AIM2, and inflam-
masome formation occurs (1). Some cells have simpler
activation pathways because they have higher basal levels
of the pro-forms of IL-1b and IL-18.
Interestingly, inflammasomes are also involved in the
homeostatic mutualism between host and commensals. In
the intestine, one inflammasome function is to control the
composition of the microbiota (36). The NLCP4 inflam-
masome, expressed by intestinal phagocytes in particular,
plays a major role to discriminate between commensal
and pathogenic microbes and initiate a harmful res-
ponse to the latter (37). Thus, inflammasomes may have a
variety of roles regulating homeostasis in the intestinal
tract and microbial ecology preventing the emergence of
pathobionts (25, 38). Inflammasome-deficient mice ex-
hibited an aberrant microbial community that triggered
an enhanced inflammatory reaction in the intestine (39).
This microbial dysbiosis affected the physiology and
pathophysiology both locally in the intestine and sys-
temically and might contribute to the pathogenesis of
intestinal bowel disease (10).
The NLRP3 inflammasome
NLRP3 is part of one of the best-studied inflammasome
complexes. It consists of the NLRP3 scaffold, the ASC
adaptor, and procaspase-1 (3). Two steps are required to
activate the NLRP3 inflammasome (25). The first step is
initiated by microbial ligands or endogenous cytokines
and is needed to induce upregulation of NLRP3 protein
expression (2, 40). NF-rB activation and reactive oxygen
species (ROS) are required for this step. The second step
is activation of NLRP3 by microbial stimuli or endo-
genous molecules (25). NLRP3 is activated by several
microbial-derived ligands, including toxins (20, 37). The
endogenous signals triggering NLRP3 activation include
the danger signal ATP, fatty acids, particulate matter,
necrosis, and necroptosis (reviewed by Hao et al. (25)).
Also K efflux, lysosome function, endoplasmic reticu-
lum (ER) stress, intracellular calcium, ubiquitination,
microRNAs, and particularly ROS have been proposed
(reviewed by Abais et al. (19)) (Fig. 2). ROS may serve
a ‘kindling’ or triggering factor for activation of the
NLRP3 inflammasome as well as ‘bonfire’ or ‘effector’
molecules leading to pathological processes (19).
In monocytes and dendritic cells, TLR stimulation is
adequate to induce caspase-1 activation and IL-1b produc-
tion but not in macrophages (reviewed by Hao et al. (25)).
Fig. 1. Major inflammasomes with known stimulators. In NLPR1 muramyl dipeptide and Bacillus anthracis lethal toxin can
directly cause caspase-5 processing. NLRC4 activation is mostly related to components of Gram-negative bacteria. In AIM2,
double-stranded DNA (dsDNA) binds to the HIN200 domain and requires ASC for processing of caspase-1. Also, NLPR3
requires ASC and caspase-1. It is activated in response to both exogenous and endogenous danger signals. (From ref. 19 with
permission.)
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In human monocytes, TLR stimulation promotes extra-
cellular release of ATP which in turn stimulates the
purinergic receptor P2X7 needed for activation of the
NLRP3 inflammasome. In dendritic cells, however, NLRP3
activation is independent of P2X7 (41). This implies that
in some cell types TLR can activate the NLRP3 in-
flammasome independent of extracellular mediators such
as ATP. All NLRP3s have a unique sensor protein of the
NLR or the PYHIN superfamily. These proteins seem to
possess numerous mechanisms for sensing bacteria and
initiating immune mechanisms (10).
The AIM2 inflammasome
AIM2 is a cytosolic binding receptor for double-stranded
DNA (1). It is known to form an inflammasome and
activate caspase-1 when bacteria and viruses are present
(4244). AIM2 consists of an N-terminal pyrin domain
and a C-terminal DNA-binding HIN200 domain. It is
the only known HIN200 domain-containing protein with
capacity to mature IL-1b and IL-18 through interactions
with ASC and caspase-1 (42). The AIM2 inflammasome
is particularly important in the defense against intracel-
lular bacterial and viral pathogens (43, 44).
Fig. 2. Activation of the NLRP3 inflammasome as a two-step mechanism. Primary signals come from activation of toll-like
receptors (TLRs) which are responsible for the upregulation of NLRP3 and pro-interleukin-1b (IL-1b) in an NF-kB-dependent
manner. Secondary signals come from several pathways: K efflux via P2X7 receptor activation via ATPe coupling, endoplasmic
reticulum (ER) stress, mitochondrial dysfunction, NADPH oxidase, frustrated phagocytosis, and lysosomal rupture pathways. All
these primary and secondary signals converge in the production of reactive oxygen species (ROS). (From ref. 19 with permission.)
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P. gingivalis
Synergy
Several opportunistic pathogens have been shown to
develop different mechanisms to inhibit inflammasome
activation and function. Similarly, P. gingivalis, a proposed
keystone organism in chronic periodontitis (17), has been
found to manipulate innate immunity via a number of
mechanisms (18). This bacterium has been postulated to
suppress inflammasome activation as a mechanism for its
low immunostimulatory activity and pathogenic synergy
with other periodontal bacteria that are shown to be more
immunogenic (45). P. gingivalis can also suppress inflam-
masome activation by Fusobacterium nucleatum and this
may be a contribution from P. gingivalis to the synergy
between the two periodontal bacteria (4649). This
specific inhibition appears to affect IL-1b and IL-18
processing and cell death in macrophages of both man
and mouse. While F. nucleatum activated IL-1b proces-
sing through the NLRP3 inflammasome, P. gingivalis
mediated repression was not related to lowered levels of
inflammasome components (45). P. gingivalis infection
also influences endocytosis by preferentially suppressing
endocytic pathways toward inflammasome activation.
This represents a new mechanism of pathogen-mediated
inflammasome inhibition (45). It should also be noted
that although P. gingivalis inhibits an activation path-
way that can kill the microrganism; this may not be the
integral part of a general immune suppression strategy as
P. gingivalis harnesses acute sustained inflammation that
is relatively harmless to the bacterium. Indeed, period-
ontitis-associated bacteria could benefit from a nutrition-
ally favorable inflammatory environment created by P.
gingivalis (50).
Nucleoside-diphosphate kinase
P. gingivalis uses its extracellularly secreted nucleoside-
diphosphate kinase homologue (NDK) (51) to inhibit
innate immune responses due to stimulation by extracel-
lular ATP (ATPe) (52). ATPe acts as a danger signal that
can alert the immune system about a present infection.
ATPe binds to P2X7 receptors (see below) and activates an
inflammasome and caspase-1. Infection of gingival epithe-
lial cells (GECs) resulted in inhibition of ATP-induced
caspase-1 activation (52). ndk-deficient P. gingivalis was
less effective in limiting ATP-mediated caspase-1 activa-
tion and secretion of IL-1b from infected cells. NDK
therefore seems to play an important role in inhibiting
P2X7-dependent inflammasome activation. The conse-
quent inhibition of P2X7-mediated apoptosis and exten-
sion of the viability of GECs could make P. gingivalis
survive for extended periods of time in the gingival
epithelium and contribute to disease when other host and
bacterial factors participate in tissue destruction. NDK
also reduced ATPe-mediated plasma membrane permea-
bilization of host cells in a dose-dependent manner (53).
In GECs, NDK of P. gingivalis promoted intracellular
persistence by inhibiting ATP-induced ROS via P2X7
receptor/NADPH oxidase signaling (54). This implied
that GECs produced significant amounts of ROS in
response to ATPe and that this depended on P2X7-
signaling coupled with membrane-bound NADP oxidase
and the mitochondrial respiratory chain. This novel sig-
naling cascade may contribute to successful tissue per-
sistence of this major pathogen.
Also, the secreted multi-functional effector molecule,
NDK from P. gingivalis attenuated release of the high-
mobility group protein B1 (HMGB1) (52). HMGB1 is a
pro-inflammatory danger signal associated with chroma-
tin in healthy cells. Lack of NDK reduced significantly
the inhibition of ATP-dependent inflammasome activa-
tion and the release of pro-inflammatory cytokines in
GECs (52). The findings suggested that NDK could play
a significant role in the inhibition of P2X7 -dependent
inflammasome activation and HMGB1-release from
infected GECs.
The P2X7 and P2X4 receptors
The P2X7 purinergic cell surface receptor, which is
expressed on a variety of immune cells, including macro-
phages, functions as a second signal for assembly of the
NLRP3 inflammasome (55). Purinergic signaling is
essential for the release of IL-1b from cells infected
with P. gingivalis (56). In macrophages P2X7 has a dual
role, as it was critical not only for ATPe-induced IL-1b
secretion in vitro but also for intracellular pro-IL-1b
processing (57). These findings also applied to the in vivo
situation since the P2X7 receptor expression was upregu-
lated in a P. gingivalis oral infection model. Further, the
P2X7 receptor and NLRP3 transcription were found to
be modulated in human chronic periodontitis (57), sug-
gesting that the P2X7 receptor also has a role in period-
ontal immunopathogenesis. The ability of P. gingivalis to
modulate ATP-/P2X7-signaling, to secrete NDK during
infection in primary GECs, and its expression of other
virulence factors, for example, gingipains and fimbriae,
and promotion of peripheral artery disease (PAD) may
link this bacterium to periodontitis and other systemic
diseases such as rheumatoid arthritis, diabetes, obesity,
multiple sclerosis, and pancreatic and kidney diseases
(58, 59). Interestingly, gingipains may also affect inflam-
masome activation. Jung et al. (60) recently showed that
the simultaneous protease action of Kgp and Rgps atten-
uates the caspase-1 activating potential of P. gingivalis in
macrophages.
It is well known that infection of GECs with P.
gingivalis requires an exogenous danger signal such as
ATPe for activation of an inflammasome and caspase-1.
This again will induce secretion of IL-1b. Generation
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of ROS is also stimulated by ATPe. However, the
mechanism of ROS generation and the role of purinergic
receptors in inflammasome activation were not very clear
until Hung et al. (61) demonstrated that the purinergic
receptor P2X4 is assembled with P2X7 and its associated
pore, pannexin-1. ROS production was induced by ATPe
through a complex containing P2X4, P2X7, and pannexin-1.
The P2X7-mediated ROS production can activate the
NLPR3 inflammasome and caspase-1. Activation by
P2X4 alone induced generation of ROS but not inflam-
masome activation. Depletion or inhibition of P2X4,
P2X7, or the pannexin complex markedly blocked IL-1b
secretion in P. gingivalis-infected GECs after ATPe treat-
ment (61). Accordingly, ROS is produced by stimulation
of the P2X4/P2X7/pannexin-1 complex. This also means
that P2X4 acts as a positive regulator of inflammasome
activation during infection with P. gingivalis.
A2a adenosine receptor
Danger signals (DS) are molecules like adenosine that
exert extracellular signaling derived from autocrine and/
or paracrine secretions during inflammation and chronic
diseases. Adenosine, which is a metabolite of ATP, has
so far been little appreciated as a component of the innate
immune system (62). ATPe is produced through a num-
ber of enzymatic reactions in normal, stressed, or infected
tissues (63). It has recently been shown that P. gingivalis
can use A2A adenosine receptorcoupled DS adenosine
signaling as a means to proliferate and survive in primary
GECs, possibly by down-regulating the pro-inflammatory
response (62). P. gingivalis reduces extracellular nucleo-
tide concentrations of ATP and thereby acts as a gen-
erator of adenosine which stimulates the bacterium’s
growth in primary GECs. This may be another anti-
inflammatory immune response exerted by P. gingivalis to
promote its survival in the oral mucosa.
Phosphatidylserine
During Chlamydia infection of human epithelial, en-
dothelial, granulocyte, or monocytic cells, phosphatidyl-
serine (PS) is translocated from the inner to the outer
leaflet and becomes exposed to the external side of the
cell (64). PS exposure is an early marker of apoptosis
associated with pro-inflammatory triggering of comple-
ment activation (65, 66). Yilmaz et al. (67) found that P.
gingivalis after establishing itself in the nutritionally rich
cytosol of the host cell can protect the infected cell from
the host immune defense by reducing the inflammatory
response after inducing transient externalization of PS.
This would allow multiplication of P. gingivalis inside
cells while protecting them from cytotoxic reactions
of the immune system. It was also suggested that the
bacterium blocks mitochondrion-dependent apoptosis to
upkeep its intracellular lifestyle. This may permit success-
ful spreading of P. gingivalis to adjacent and deeper host
tissues.
Inflammasome activity in P. gingivalisinduced
periodontal disease and defense
GECs are important parts of the immune response to
periodontal bacteria. They express a functional NLRP3
inflammasome (68). Much higher levels of inflamma-
some components were found in the gingival tissues from
patients with chronic periodontitis than from healthy
controls (14). It therefore seems reasonable to consider
the inflammasome as an operational part of innate im-
munity against periodontitis.
While supragingival biofilm, causing gingivitis, in-
creased the expression of caspase-1, ASC, AIM2, IL-
1b, and IL-18 in gingival fibroblasts, subgingival biofilm,
promoting periodontitis, enhanced caspase-1, ASC,
AIM2, IL-1b, and IL-18 gene expression at lower
concentrations, followed by their downregulation at
higher concentrations (69). The authors proposed that
high concentrations of bacterial virulence factors in sites
with affluent immune mechanisms such as the biofilm-
tissue interface can down-regulate host defense barriers,
while the lower bacterial concentrations deeper in period-
ontal tissues can have a stimulatory effect on inflamma-
tory responses.
When using a 10-species subgingival biofilm with P.
gingivalis present, Belibasakis et al. (70) found a reduc-
tion in NLRP3 and IL-1b expression in human gingival
fibroblasts after challenge for 6 h. The AIM2 expression
was not affected. After exclusion of P. gingivalis from the
biofilm, a partial rescue of NLRP3 and IL-1b-expression
occurred. It was suggested that subgingival biofilms
down-regulate NLRP3 and IL-1b expression partly due
to P. gingivalis and that this dampening of the host innate
immune responses may favor persistence and survival of
biofilm species in periodontal tissues.
It has been recently shown that fimbriae of P. gingivalis
inhibit ATPe-induced IL-1b secretion through the
P2X7 receptor in macrophages (56). Ramos-Junior
et al. (57), however, found that NLRP3 is necessary for
ATPe-induced IL-1b secretion as well as for caspase-1
activation irrespective of P. gingivalis fimbriae. Although
IL-1b secretion from P. gingivalisinfected macrophages
depended on NLRP3, its adaptor protein ASC, or
caspase-1, the cleavage of intracellular IL-1b to the
mature form occurred independently of NLRP3, its
adaptor protein ASC, or caspase-1.
P. gingivalis dampened ATPe-induced IL-1b secretion
in macrophages by means of its fimbriae in a purinergic
P2X7 receptor-dependent manner (56). In this study,
the immune subversion of P. gingivalis was connected
with the ability of fimbriae to reduce ATPe-induced
macrophage secretion of IL-1b via P2X7 activation. The
authors held that this could be another molecular action
of subversion of the immune system by P. gingivalis.
In THP-1 (leukemic monocytic) cells, P. gingivalis
induced IL-1b secretion and inflammatory cell death
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through activation of caspase-1 (14). IL-1b secretion and
pyroptic cell death required both NLRP3 and AIM2
inflammasome activation via TLR2 and TLR4 signaling.
The activation of the former was mediated by ATP
release, the P2X7 receptor, and lysosomal damage (14).
These authors also suggested that P. gingivalisinduced
NLRP3 activation depends on ATP release, K efflux,
and cathepsin B.
Underacylated lipopolysaccharide
P. gingivalis can use lipid A phosphatase to alter the lipid
A composition of its lipopolysaccharide (LPS). This
organism may therefore modulate the immune response
by expressing an underacylated LPS (7173). This LPS
could bind but not activate caspase-11 (human caspase-
4,5) which results in host cell lysis and reduces sur-
vival of bacteria (72, 74). Caspase-4 can be of specific
importance to mucosal immunity since caspase-4 expres-
sion level and ability to become activated as a response
to infection differ markedly from that of caspase-5.
Caspase-4 has been suggested to provide key non-
redundant discernment into rapid sensing and clearance
of bacteria at mucosal tissues (21).
Atherosclerosis
There is mounting evidence that P. gingivalis can invade
cardiovascular cells and tissues causing inflammation
(75). The NLRP3 inflammasome has been suggested to
have an important role in developing vascular inflam-
mation and atherosclerosis (76, 77). In hyperlipidemic
animals, P. gingivalis accelerated atherosclerosis (78). Wild-
type challenge of apolipoprotein Edeficient, sponta-
neously hyperlipidemic (Apoeshl) mice with P. gingivalis
increased IL-1b, IL-18, and TNF-a production in peri-
toneal macrophages and gingival or aortic gene expres-
sion of the NOD-like receptor family, NLRP3, IL-1b,
pro-IL-18 and pro-caspase-1 (78). Fimbriae were found to
bring increased tissue invasiveness and pro-inflammatory
ability to P. gingivalis. It was also demonstrated that
P. gingivalis activates innate immune cells through the
NLRP3 inflammasome compared with a KDP136 (gingipain-
null) or a KDP150 (FimA-deficient) mutant.
Inflammation-related induction of AIM2 in vascular
cells and atherosclerotic lesions has suggested a role for
AIM2 in vascular pathogenesis where increased AIM2
expression was seen around the necrotic core of athero-
sclerotic carotid lesions and in the vasa vasorum of
neovasculature of aortic aneurysms (79). The NLRP3
inflammasome and AIM2 may thus have important roles
in both P. gingivalisinduced periodontal disease and
atherosclerosis through sustained inflammation.
Recently, the CD36/scavenger receptor (SR)-B2 was sug-
gested to play a role at multiple points in P. gingivalis
mediated enhanced atherosclerosis in a mouse model
(80). The study suggested that activation of the inflam-
masome by P. gingivalis is mediated by CD36/SR-B2 and
TLR2 which cause systemic release of pro-atherosclerotic
IL-1b and macrophage pyroptosis. Systemic IL-1b acti-
vates vascular macrophages naı¨ve to P. gingivalis to
secrete IL-1b and promotes CD36-mediated uptake of
oxLDL and increased formation of foam cells. The
presence of oxLDL could inhibit P. gingivalis/P. gingivalis
LPS-inflammasome activation and pyroptosis, which
would allow greater atherosclerotic plaque to develop.
TLR-CD36-/SR-B2-mediated IL-1b generation may thus
be important to increase atherosclerotic lesions. Of note
is also that cytoplasmic LPS sensing in human cells
activates the non-canonical caspase-4-dependent inflam-
masome. This is a new mechanism of inflammasome
activation where direct LPS-binding results in caspase
oligomerization and activation leading to induction of
IL-1b secretion and pyroptosis (81).
Alzheimer’s disease
P. gingivalis may be an important pathogen in Alzhei-
mer’s disease (AD) contributing to brain inflammation
(82). NLRP3 has been reported in microglial cells that
responded to infection and initiation of neuro-degeneration
in an Alzheimer’s disease model (83). Furthermore,
TLR2 and NLRP3 were recently found to co-operate to
recognize a functional bacterial amyloid, curli fibers, in
the plaques of brains in AD patients (84). Heneka et al.
(85) found a strongly activated caspase-1 expression in
human mild cognitive impairment and AD brains which
suggested a role for the inflammasome in brain degen-
erative disease. AD brain deposits activated the NLRP3
inflammasome in microglial cells in vitro and in vivo
which could lead to progression of AD (8588). This
suggested a role for the inflammasome in this neurode-
generative disease.
Non-alcoholic steatohepatitis
P. gingivalis seems to be a critical risk factor for pro-
gression of non-alcoholic steatohepatitis (NASH) through
upregulation of the P. gingivalis-LPS-TLR2-pathway and
by stimulating inflammasomes (89). These authors found
that P. gingivalis exacerbated steatohepatitis induced by
diet via induction of inflammasomes and inflammatory
cytokines in the liver of mice. P. gingivalis was also
demonstrated for the first time in the liver of NASH
patients. It was suggested that dental infection with P.
gingivalis promotes progression of NASH.
Squamous cell carcinoma
A close association has been found between P. gingivalis
and squamous cell carcinoma (90). The fact that P.
gingivalis modulates ATP-/P2X7-signaling; secretes the
anti-apoptotic enzyme, NDK, during infection of primary
OECs; and expresses other virulence factors, such as
fimbriae, gingipains, and PAD, that may be potential
etiologic links to orodigestive cancers and other chronic
diseases (58, 59). Of note is also that IL-1b promotes
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malignant transformation of tumor aggressiveness in oral
cancer (91).
Rheumatoid arthritis
Periodontitis is more prevalent in patients with rheuma-
toid arthritis (RA) than in those without (92). RA is also
prevalent in patients with periodontitis (93). Besides,
there is improvement in RA after periodontal treatment
and in periodontitis after treatment of RA (94, 95).
Furthermore, DNA from a variety of oral bacteria,
including P. gingivalis, has been detected in synovial fluid
of active RA (96). Bostanci et al. (97) found a positive
correlation between NLRP3 and expression of IL-1b and
IL-18 in periodontitis, and upregulated levels of NLRP3,
AIM2, and caspase-1 have been detected in gingival
tissues of patients with periodontitis (14). Probably, P.
gingivalis manipulates the host inflammatory responses
to be able to survive and prevail within infected period-
ontal tissues (97), which it may achieve by limiting or
controlling the activation of the NLRP3 inflammasome.
It seems reasonable to expect similar effects in distant
sites, for example, in the joints of rheumatic patients
where P. gingivalis can be present.
Concluding remarks
Inflammasomes represent a relatively new concept in
innate immunity. There is great variation in inflamma-
somes and the mechanisms by which they detect and resist
pathogens. Many interactions between inflammasomes
and the innate immune system are still unknown. It is
becoming clear that the inflammasome and its constitu-
ents are likely crucial in the initiation of periodontal
disease and several chronic systemic diseases associated
with periodontitis. Nevertheless, it may be difficult to
intervene in inflammasome actions for the purpose of
treating disease since interfering with key parts in the
complex may have serious local and systemic effects. The
ubiquitous distribution and importance of inflammasome
activation in many peripheral processes adds to this
limitation. There are still not fully understood roles of all
players in the inflammasome complex where anti-inflam-
matory therapies might not be sufficient to treat the roots
of the disease. Knowledge about inflammasomes has
mainly been retrieved from murine systems. The applic-
ability of some of these results to human cells is unclear
because gene products differ between species, and the
specificity of ligands is not always conserved. P. gingivalis
has a number of ways for suppressing innate immunity
and inflammasome activity. Although this subversion
probably is important for periodontitis and some related
systemic diseases, it remains to see if other parts of the oral
microbiota can behave in a similar way and if this sub-
version can affect players other than F. nucleatum in the
dental biofilm. Efforts should also be made to see how
inflammasomes can affect the ecology of the dental plaque
microbiota.
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